Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 08/31/2021

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Biotechnology Opportunities Portfolio, Series 2020-1

BIOAAX | Fund

$15.16

-

0.00%

0.40%

Vitals

YTD Return

4.7%

1 yr return

15.1%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$N/A

Holdings in Top 10

58.0%

52 WEEK LOW AND HIGH

$15.0
$11.45
$18.36

Expenses

OPERATING FEES

Expense Ratio 0.40%

SALES FEES

Front Load 0.00%

Deferred Load 2.25%

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

$1,000

IRA

N/A

Fund Classification

Fund Type

Unknown

Name

As of 08/31/2021

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Biotechnology Opportunities Portfolio, Series 2020-1

BIOAAX | Fund

$15.16

-

0.00%

0.40%

BIOAAX - Profile

Distributions

  • YTD Total Return 4.7%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Biotechnology Opportunities Portfolio, Series 2020-1
  • Fund Family Name
    Advisors Asset Management, Inc.
  • Inception Date
    May 01, 2020
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States

Fund Description

BIOAAX - Performance

Return Ranking - Trailing

Period BIOAAX Return Category Return Low Category Return High Rank in Category (%)
YTD 4.7% -38.9% 25.3% 15.45%
1 Yr 15.1% -60.2% 33.9% 9.60%
3 Yr N/A* -10.0% 19.7% N/A
5 Yr N/A* -6.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Return Ranking - Calendar

Period BIOAAX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -79.9% 25.9% N/A
2022 N/A -13.6% 178.2% N/A
2021 N/A 3.8% 63.8% N/A
2020 N/A -49.7% 21.5% N/A
2019 N/A -59.8% 54.4% N/A

Total Return Ranking - Trailing

Period BIOAAX Return Category Return Low Category Return High Rank in Category (%)
YTD 4.7% -46.5% 25.3% 15.45%
1 Yr 11.9% -60.2% 31.1% 17.19%
3 Yr N/A* -15.9% 20.0% N/A
5 Yr N/A* -7.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Total Return Ranking - Calendar

Period BIOAAX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -79.9% 25.9% N/A
2022 N/A -13.6% 178.2% N/A
2021 N/A 3.8% 63.8% N/A
2020 N/A -49.7% 22.2% N/A
2019 N/A -59.8% 54.4% N/A

NAV & Total Return History

BIOAAX - Holdings

Concentration Analysis

BIOAAX Category Low Category High BIOAAX % Rank
Net Assets N/A 732 K 46.2 B N/A
Number of Holdings 33 11 473 83.20%
Net Assets in Top 10 5.8 K 2.18 K 21.6 B 90.57%
Weighting of Top 10 58.04% 12.3% 94.7% 11.48%

Top 10 Holdings

  1. Novavax Inc 19.87%
  2. Fate Therapeutics Inc 6.02%
  3. Biohaven Pharmaceutical Holding Co Ltd 5.26%
  4. CRISPR Therapeutics AG 4.83%
  5. AstraZeneca PLC ADR 4.46%
  6. Genmab A/S ADR 3.73%
  7. Dicerna Pharmaceuticals Inc 3.71%
  8. Halozyme Therapeutics Inc 3.62%
  9. United Therapeutics Corp 3.32%
  10. Thermo Fisher Scientific Inc 3.21%

Asset Allocation

Weighting Return Low Return High BIOAAX % Rank
Stocks 		100.00% 85.37% 106.13% 31.15%
Preferred Stocks 		0.00% 0.00% 7.86% 97.54%
Other 		0.00% -22.99% 3.38% 93.03%
Convertible Bonds 		0.00% 0.00% 0.37% 97.54%
Cash 		0.00% -0.10% 9.01% 97.54%
Bonds 		0.00% 0.00% 12.39% 97.54%

Stock Sector Breakdown

Weighting Return Low Return High BIOAAX % Rank
Healthcare 		100.00% 59.26% 100.00% 53.28%
Utilities 		0.00% 0.00% 0.00% 97.54%
Technology 		0.00% 0.00% 22.69% 97.54%
Real Estate 		0.00% 0.00% 7.13% 97.54%
Industrials 		0.00% 0.00% 7.02% 97.54%
Financial Services 		0.00% 0.00% 1.85% 98.36%
Energy 		0.00% 0.00% 0.00% 97.54%
Communication Services 		0.00% 0.00% 9.11% 97.54%
Consumer Defense 		0.00% 0.00% 25.73% 97.54%
Consumer Cyclical 		0.00% 0.00% 14.20% 97.54%
Basic Materials 		0.00% 0.00% 14.83% 98.36%

Stock Geographic Breakdown

Weighting Return Low Return High BIOAAX % Rank
US 		85.24% 53.67% 104.41% 61.07%
Non US 		14.76% 0.00% 45.40% 32.38%

BIOAAX - Expenses

Operational Fees

BIOAAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.40% 0.08% 3.13% 71.02%
Management Fee N/A 0.00% 1.25% N/A
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BIOAAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 0.00% 0.00% 5.75% 96.43%
Deferred Load 2.25% 1.00% 5.00% 54.32%

Trading Fees

BIOAAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIOAAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% N/A

BIOAAX - Distributions

Dividend Yield Analysis

BIOAAX Category Low Category High BIOAAX % Rank
Dividend Yield 0.00% 0.00% 3.95% 14.52%

Dividend Distribution Analysis

BIOAAX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

BIOAAX Category Low Category High BIOAAX % Rank
Net Income Ratio N/A -2.54% 1.92% N/A

Capital Gain Distribution Analysis

BIOAAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Semi-Annually

Distributions History

View More +

BIOAAX - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.54 2.12

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.